ABOUT REZON BIO
Rezon Bio is a science-driven contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian biologics. Headquartered in Poland, Rezon Bio offers integrated solutions spanning cell line development, commercial drug substance manufacturing, and drug product development. The company operates with state-of-the-art facilities, world-class teams, and a proven track record of regulatory and commercial success. Drawing on a legacy of biosimilars development and global commercialization, Rezon Bio combines experience, digital transparency, and cost-to-value efficiency to help clients move from concept to market with confidence.
INDUSTRY INSIGHTS
-
![The Hidden Challenges Of Biologics Development]( "The Hidden Challenges Of Biologics Development")
Biologics development leaders discuss industry challenges, including innovation pressures, operational complexity, leadership decisions, and maintaining quality and resilience in an evolving landscape.
-
![GettyImages-505766677-team-meeting-collaboration-group-teamwork-discussion]( "Delivering CDMO Excellence, Quality, And Value Through Dedication")
A biologics CDMO combines scientific expertise, flexibility, and partnership to deliver high-quality, cost-efficient development and manufacturing solutions from early stages to commercialization.
CONTACT INFORMATION
Rezon Bio
Trzy Lipy 3, Building A
Gdansk, 80-172
POLAND
Contact: Loukiani Chatzinasiou
SOLUTIONS
-
![clinical-drug-development-GettyImages-1354172647]( "Where Dedication Delivers Value")
Explore a science-driven CDMO offering end-to-end biologics development and manufacturing, with robust quality, scalable capacity, and expertise from clinical to commercial production.
-
![rezon bio integrated biologics]( "Rezon Bio Capabilities Update May 2026: Large Molecule")
Discover how tailored biologics development strategies can improve scalability, reduce tech transfer risk, and create more reliable pathways from early development to commercial supply.
